155 related articles for article (PubMed ID: 30707898)
1. A simple fluorescent assay for the discovery of protein-protein interaction inhibitors.
Al-Mugotir M; Kolar C; Vance K; Kelly DL; Natarajan A; Borgstahl GEO
Anal Biochem; 2019 Mar; 569():46-52. PubMed ID: 30707898
[TBL] [Abstract][Full Text] [Related]
2. Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
Al-Mugotir M; Lovelace JJ; George J; Bessho M; Pal D; Struble L; Kolar C; Rana S; Natarajan A; Bessho T; Borgstahl GEO
PLoS One; 2021; 16(3):e0248941. PubMed ID: 33784323
[TBL] [Abstract][Full Text] [Related]
3. Human RAD52 interactions with replication protein A and the RAD51 presynaptic complex.
Ma CJ; Kwon Y; Sung P; Greene EC
J Biol Chem; 2017 Jul; 292(28):11702-11713. PubMed ID: 28551686
[TBL] [Abstract][Full Text] [Related]
4. Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers.
Chandramouly G; McDevitt S; Sullivan K; Kent T; Luz A; Glickman JF; Andrake M; Skorski T; Pomerantz RT
Chem Biol; 2015 Nov; 22(11):1491-1504. PubMed ID: 26548611
[TBL] [Abstract][Full Text] [Related]
5. FRET-based assays to monitor DNA binding and annealing by Rad52 recombination mediator protein.
Grimme JM; Spies M
Methods Mol Biol; 2011; 745():463-83. PubMed ID: 21660711
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells.
Hengel SR; Malacaria E; Folly da Silva Constantino L; Bain FE; Diaz A; Koch BG; Yu L; Wu M; Pichierri P; Spies MA; Spies M
Elife; 2016 Jul; 5():. PubMed ID: 27434671
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Imaging of Small Molecule Induced Protein-Protein Interactions in Living Cells with a Fluorophore Phase Transition Based Approach.
Chung CI; Zhang Q; Shu X
Anal Chem; 2018 Dec; 90(24):14287-14293. PubMed ID: 30431263
[TBL] [Abstract][Full Text] [Related]
8. Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions.
Laraia L; McKenzie G; Spring DR; Venkitaraman AR; Huggins DJ
Chem Biol; 2015 Jun; 22(6):689-703. PubMed ID: 26091166
[TBL] [Abstract][Full Text] [Related]
9. Streamline proteomic approach for characterizing protein-protein interaction network in a RAD52 protein complex.
Du Y; Zhou J; Fan J; Shen Z; Chen X
J Proteome Res; 2009 May; 8(5):2211-7. PubMed ID: 19338310
[TBL] [Abstract][Full Text] [Related]
10. Effective cell-free drug screening protocol for protein-protein interaction.
Ashkenazi S; Plotnikov A; Bahat A; Dikstein R
Anal Biochem; 2017 Sep; 532():53-59. PubMed ID: 28579488
[TBL] [Abstract][Full Text] [Related]
11. Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors.
Huang F; Goyal N; Sullivan K; Hanamshet K; Patel M; Mazina OM; Wang CX; An WF; Spoonamore J; Metkar S; Emmitte KA; Cocklin S; Skorski T; Mazin AV
Nucleic Acids Res; 2016 May; 44(9):4189-99. PubMed ID: 26873923
[TBL] [Abstract][Full Text] [Related]
12. Human RAD52 Captures and Holds DNA Strands, Increases DNA Flexibility, and Prevents Melting of Duplex DNA: Implications for DNA Recombination.
Brouwer I; Zhang H; Candelli A; Normanno D; Peterman EJG; Wuite GJL; Modesti M
Cell Rep; 2017 Mar; 18(12):2845-2853. PubMed ID: 28329678
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection.
Sullivan K; Cramer-Morales K; McElroy DL; Ostrov DA; Haas K; Childers W; Hromas R; Skorski T
PLoS One; 2016; 11(1):e0147230. PubMed ID: 26784987
[TBL] [Abstract][Full Text] [Related]
14. Dynamic regulatory interactions of rad51, rad52, and replication protein-a in recombination intermediates.
Sugiyama T; Kantake N
J Mol Biol; 2009 Jul; 390(1):45-55. PubMed ID: 19445949
[TBL] [Abstract][Full Text] [Related]
15. Yeast Srs2 Helicase Promotes Redistribution of Single-Stranded DNA-Bound RPA and Rad52 in Homologous Recombination Regulation.
De Tullio L; Kaniecki K; Kwon Y; Crickard JB; Sung P; Greene EC
Cell Rep; 2017 Oct; 21(3):570-577. PubMed ID: 29045827
[TBL] [Abstract][Full Text] [Related]
16. High-throughput fluorescence assay for membrane-protein interaction.
Kim H; Afsari HS; Cho W
J Lipid Res; 2013 Dec; 54(12):3531-8. PubMed ID: 24006510
[TBL] [Abstract][Full Text] [Related]
17. A fluorescent-based high-throughput screening assay for small molecules that inhibit the interaction of MdmX with p53.
Tsuganezawa K; Nakagawa Y; Kato M; Taruya S; Takahashi F; Endoh M; Utata R; Mori M; Ogawa N; Honma T; Yokoyama S; Hashizume Y; Aoki M; Kasai T; Kigawa T; Kojima H; Okabe T; Nagano T; Tanaka A
J Biomol Screen; 2013 Feb; 18(2):191-8. PubMed ID: 22989451
[TBL] [Abstract][Full Text] [Related]
18. Fr-PPIChem: An Academic Compound Library Dedicated to Protein-Protein Interactions.
Bosc N; Muller C; Hoffer L; Lagorce D; Bourg S; Derviaux C; Gourdel ME; Rain JC; Miller TW; Villoutreix BO; Miteva MA; Bonnet P; Morelli X; Sperandio O; Roche P
ACS Chem Biol; 2020 Jun; 15(6):1566-1574. PubMed ID: 32320205
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
[TBL] [Abstract][Full Text] [Related]
20. Integrating Experimental and In Silico HTS in the Discovery of Inhibitors of Protein-Nucleic Acid Interactions.
Li Q; Folly da Silva Constantino L; Spies MA
Methods Enzymol; 2018; 601():243-273. PubMed ID: 29523234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
